OBJECTIVE: To determine the risk factors and clinical significance of anti-PGL-I seropositivity. DESIGN: A large-scale sero-epidemiological study (COLEP) was carried out in northwest Bangladesh. Blood on filter paper from 1025 newly diagnosed patients was collected before treatment was started and tested with an anti-PGL-I ELISA; the relation between patient determinants and seropositivity was calculated using logistic regression. RESULTS: The median age was 30 years and the male:female ratio 1.9. Overall, 342 patients (33.4%) were seropositive. The following determinants showed a significant correlation with seropositivity (P < 0-05) in multivariate analysis: sex, age, disability grade, bacterial index and classification according to the World Health Organization (WHO) system. The number and extent of clinical signs correlated with seropositivity, except for the presence of satellite lesions. People with or without a BCG vaccination scar had a similar risk to be seropositive. CONCLUSION: Serology is a marker for a higher systemic bacterial load and may identify potential infectious sources among patients with few clinical signs. The size of skin lesions was positively correlated with seropositivity. We did not find different levels of seropositivity among patients with one or two skin lesions, neither did we find different levels among patients with or without satellite
OBJECTIVE: To determine the risk factors and clinical significance of anti-PGL-I seropositivity. DESIGN: A large-scale sero-epidemiological study (COLEP) was carried out in northwest Bangladesh. Blood on filter paper from 1025 newly diagnosed patients was collected before treatment was started and tested with an anti-PGL-I ELISA; the relation between patient determinants and seropositivity was calculated using logistic regression. RESULTS: The median age was 30 years and the male:female ratio 1.9. Overall, 342 patients (33.4%) were seropositive. The following determinants showed a significant correlation with seropositivity (P < 0-05) in multivariate analysis: sex, age, disability grade, bacterial index and classification according to the World Health Organization (WHO) system. The number and extent of clinical signs correlated with seropositivity, except for the presence of satellite lesions. People with or without a BCG vaccination scar had a similar risk to be seropositive. CONCLUSION: Serology is a marker for a higher systemic bacterial load and may identify potential infectious sources among patients with few clinical signs. The size of skin lesions was positively correlated with seropositivity. We did not find different levels of seropositivity among patients with one or two skin lesions, neither did we find different levels among patients with or without satellite
Authors: Malcolm S Duthie; Greg C Ireton; Ganga V Kanaujia; Wakako Goto; Hong Liang; Ajay Bhatia; Jean Marie Busceti; Murdo Macdonald; Kapil Dev Neupane; Chaman Ranjit; Bishwa Raj Sapkota; Marivic Balagon; Javan Esfandiari; Darrick Carter; Steven G Reed Journal: Clin Vaccine Immunol Date: 2008-08-20
Authors: Angélica da Conceição Oliveira Coelho Fabri; Ana Paula Mendes Carvalho; Sergio Araujo; Luiz Ricardo Goulart; Ana Márcia Menezes de Mattos; Henrique Couto Teixeira; Isabela Maria Bernardes Goulart; Malcolm S Duthie; Rodrigo Correa-Oliveira; Francisco Carlos Félix Lana Journal: BMC Infect Dis Date: 2015-05-30 Impact factor: 3.090
Authors: Renate A Richardus; Konrad van der Zwet; Anouk van Hooij; Louis Wilson; Linda Oskam; Roel Faber; Susan J F van den Eeden; David Pahan; Khorshed Alam; Jan Hendrik Richardus; Annemieke Geluk Journal: PLoS Negl Trop Dis Date: 2017-12-11
Authors: Anouk van Hooij; Elisa M Tjon Kon Fat; Moises Batista da Silva; Raquel Carvalho Bouth; Ana Caroline Cunha Messias; Angélica Rita Gobbo; Tsehaynesh Lema; Kidist Bobosha; Jinlan Li; Xiaoman Weng; Claudio G Salgado; John S Spencer; Paul L A M Corstjens; Annemieke Geluk Journal: Sci Rep Date: 2018-12-18 Impact factor: 4.379
Authors: André Alan Nahas; Mayara Ingrid de Sousa Lima; Isabela Maria Bernardes Goulart; Luiz Ricardo Goulart Journal: Front Immunol Date: 2018-05-30 Impact factor: 7.561